Pancreatic neuroendocrine neoplasms (panNENs) are heterogeneous neoplasms with
neuroendocrine differentiation that show characteristic clinical, histomorphologic, and …

Introduction: Since the initial approval of everolimus in 2011, there have been a number of
important changes in therapeutic/diagnostic modalities as well as classification/staging …

ABSTRACT Introduction Neuroendocrine neoplasms (NENs) are a heterogeneous group of
malignancies mainly arising in the gastroenteropancreatic (GEP) and bronchopulmonary …

Simple Summary Pheochromocytomas and paragangliomas are rare neural-crest-derived
tumors with variable prognosis. In an era of tailored treatment strategies, medical imaging …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) originate from
neuroendocrine cells in the gastrointestinal tract. They are heterogeneous, and though …

Purpose Epithelial ovarian cancer (EOC) is the leading cause of gynecologic cancer death
in the United States. Most patients will ultimately fail platinum-based chemotherapy and …

Simple Summary Despite the approval of new targeted therapies for pancreatic
neuroendocrine tumors (PanNETs) over the past decades, the early identification of resistant …

Background: Gallbladder neuroendocrine carcinoma (GB-NEC) is rare and there are few
reports at present. We sought to review the current knowledge of GB-NEC and provide …

Simple Summary Tumor resistance, both primary and acquired, is leading to increased
complexity in the nonsurgical treatment of patients with advanced panNENs, which would be …

Pancreatic neuroendocrine tumors (PNETs) are classified based on their histologic
differentiation and proliferative indices, which have been used extensively to determine …